# MEDSKAN

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medskan

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.medskin.com.cn
- Latest round: Angel (Nov 27, 2023)
- Investors on record: 1

## About

MEDSKAN, based in China, is dedicated to advancing medical technology focused on skin anti-aging, offering innovative solutions designed specifically for East Asian skin.Founded in 2023, MEDSKAN operates from Shanghai, China, specializing in the development of medical technologies for skin rejuvenation. The company has engaged in two significant deals to date, with the latest deal occurring on January 27, 2026. The founder's background and previous entrepreneurial ventures are not publicly detailed.MEDSKAN, through its subsidiary Suzhou Maikon Medical Technology Co., Ltd., focuses on innovative medical technologies for skin anti-aging. Their flagship product is the MSK ultrasound beauty skincare system, which employs advanced multi-modal ultrasound technology tailored for East Asian skin. This system enhances cellular vitality through precise stimulation of skin cells. Alongside this, the company offers unique AI capsule consumables and bioactive small molecule skin serums, developed with dermatology experts. Their products are marketed primarily to clinical medical institutions and skincare professionals across China and other Asian markets, addressing common issues such as aging and skin rejuvenation.MEDSKAN operates on a B2B revenue model, supplying its skincare devices and consumables directly to clinics and skincare professionals. Revenue streams arise from direct sales of the MSK ultrasound system and AI capsule consumables, with partnerships in dermatological clinics facilitating the distribution of their bioactive serums. Pricing structures are often negotiated for bulk purchases, supported by tailored service agreements that address specific client needs, thereby building sustainable relationships and revenue streams in the skincare sector.MEDSKAN plans to leverage its recent venture funding, raised in January 2026 from investors Sunland Capital and Shanghai Bangmei Incubation Enterprise Management Partnership, to support the launch of upcoming innovative products. The company targets expansion into new geographic markets throughout Asia, aiming for full operational presence by 2027. The funds will facilitate product development and manufacturing capabilities, ensuring readiness for market entry.

## Funding rounds

- Angel, Nov 27, 2023 — Cybernaut Investment Group

## Investors

- Cybernaut Investment Group (https://capitalatlas.ai/funds/cybernaut-investment-group) — Angel